FEATURES OF TREATMENT OF RECURRENCE OF URATE NEPHROLITHIASIS
- Авторлар: GLYBOCHKO P.V.1, GRIGORYAN V.A.1, RUDENKO V.I.1, DEMIDKO Y.L.1, DEMIDKO L.S.1
-
Мекемелер:
- Шығарылым: № 4 (2017)
- Беттер: 93-101
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277691
- ID: 277691
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Petr GLYBOCHKO
MD, professor, rector of I.M. Sechenov First Moscow State Medical University. 119991, Moscow, 24 B. Pirogovskaya St
Vagarshak GRIGORYAN
MD, professor, Urological clinic, I.M. Sechenov First Moscow State Medical University 119991, Moscow, 24 B. Pirogovskaya St
Vadim RUDENKO
MD, professor, Urological clinic, I.M. Sechenov First Moscow State Medical University. 119991, Moscow, 24 B. Pirogovskaya St
Yuri DEMIDKO
Email: demidko1@mail.ru
PhD, Urological clinic, I.M. Sechenov First Moscow State Medical University. 119991, Moscow, 24 B. Pirogovskaya St
Liliya DEMIDKO
postgraduate student of the Department of urology, I.M. Sechenov First Moscow State Medical University 119991, Moscow, 24 B. Pirogovskaya St
Әдебиет тізімі
- Beck E.M., Riehle R.A. Jr. The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J. Urol. 1991;145(1):6-9.
- Butz M. Alkalizitrat-Therapie bei rezidiverender Kalzium. Urolithiasis. Urologe (B). 1987;27:95.
- Butz M. Zitrat und Kalziumurolithiasis, perimed Fachbuch Verl.-Ges. Erlangen, 1989.
- Carson C., Naber K.G. 2004. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs. 2004;64(12):1359-73.
- Cicerello E., Merlo F., Gambaro G., Maccatrozzo L., Fandella A., Baggio B., Anselmo G. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extrcorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J. Urol. 1994;151:5-9.
- Dobardzic A.M., Dobardzic R. Epidemiological features of complicated UTI in a district hospital of Kuwait. Eur. J. Epidemiol. 1997;13(4):465-70.
- Dulce H.G., Dulce M., Butz M. Einflus von Saure- und Basenbelastung auf die Harnzusammensetzung und Loslichkeitsverhaltnisse. Fortschr. Urol. Nephrol. 1985;23:381.
- Emori T.G., Gaynes R.P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 1993;6(4):428-42.
- Ettinger B., Par C.Y., Citron J.T., Thomas C., Adamas-Huet B., Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 1997;158:2069-73.
- Griffith D.P., Osborne C.A. Infection (urease) stones. Miner Electrolyte Metab. 1987;13(4):278-85.
- Maisonneuvel N., Horrent S., Azar R., Odou. 1st International consultation on stone disease. Paris, 3-4 July 2001. Book of abstracts. № 10. p. 10.
- Moe O.W., Pearle M.S., Sakhaee K. Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int. 2011;79(4):385-92.
- Nicolle L.E. A practical guide to the management of complicated urinary tract infection. Drugs. 1997;53(4):583-92.
- Parsons C.L., Stauffer C., Mulholland S.G., Griffith D.P. Effect of ammonium on bacterial adherence to bladder transitional epithelium. J. Urol. 1984;132(2):365-6.
- Poulsen P.B., Osther P.J., Hansen B.J., Smerud K.T. 1st International Consultation on Stone Disease. Paris, 3-4 July 2001. Book of abstracts. № 31. p. 31.
- Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 1992;15 (Suppl. 1):S216-27.
- Soygur T., Akbay A., Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J. Endourol. 2002;16(3):149-5.
- Tiselius H.G., Ackermann D., Alken P., Buck C., Conort P., Gallucci M. 2002. Guidelines on urolithiasis. EAU, 2002.
- Türk C., Knoll T., Petrik A., Sarica K., Straub M., Seitz C. EAU Guidelines on diagnosis and conservative management of urolithiasis. 2011.
- Глыбочко П.В., Аляев Ю.Г. Урология. М.: ГЭОТАР-Медиа, 2014. 148 с. [Glybochko P.V., Alyaev Yu.G. Urology. Moscow: GEOTAR-Media, 2014. 148 p. (in Russ.)]
- Дзюрак В.С., Савчук В.И., Желтовская Н.И., Черненко В.В., Козарин Е.И. Использование цитратной смеси Блемарен в лечении и профилактике кальций-оксалатного нефролитиаза. Урологія. 2001;3:65-70. [Dzyurak V.S., Savchuk V.I., Zheltovskaya N.I., Chernenko V.V., Kozarin Ye.I. Use of citrate mixture Blemaren in the treatment and prevention of calcium oxalate nephrolithiasis. Urology. 2001;3:65-70 (in Ukr.)]
- Сергиенко Н.Ф., Шаплыгин Л.В., Кучиц С.Ф. Цитратная терапия в лечении уратного нефролитиаза. Урология и нефрология. 1999;2:34-6. [Sergienko N.F., Shaplygin L.V., Kuchits S.F. Citrate therapy in the treatment of urate nephrolithiasis. Urol. Nephrol. 1999;2:34-6 (in Russ.)]